Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

Silence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccines

Some analysts believe Silence’s polycythemia vera drug could be superior to a closely watched Takeda medicine. Elsewhere, the FDA spurned a radiopharmaceutical and AbCellera shares climbed to levels not seen since 2023.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Wednesday 12 August →